Subtopic Deep Dive
Preexposure Prophylaxis PWID
Research Guide
What is Preexposure Prophylaxis PWID?
Preexposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID) involves clinical trials and implementation studies evaluating adherence, efficacy, and integration with harm reduction strategies to prevent HIV transmission among this high-risk population.
Research focuses on PrEP's effectiveness in PWID, addressing barriers like stigma and criminalization. Key studies include Escudero et al. (2014) on acceptability in Canadian settings (65 citations) and Escudero et al. (2014) reviewing trial results (34 citations). Over 20 papers from 2013-2020 examine cost-effectiveness, adherence, and multilevel interventions.
Why It Matters
PrEP expansion for PWID targets HIV epidemics where syringe services falter due to stigma, as shown in Muncan et al. (2020) on healthcare disengagement (379 citations). Cost-effectiveness models by Gomez et al. (2013) demonstrate impact depends on adherence and coverage (245 citations). Integration with harm reduction, per Escudero et al. (2014), could reduce infections by prioritizing high-burden settings, informing guidelines like Tan et al. (2017) (221 citations).
Key Research Challenges
Adherence Barriers in PWID
Poor PrEP adherence stems from daily pill burdens and unstable lifestyles among PWID. Sidebottom et al. (2018) systematic review identifies feasibility issues in real-world settings (235 citations). Multilevel interventions are needed, as synthesized by Pinto et al. (2018) (235 citations).
Drug Use Stigma Impact
Stigma discourages PWID from healthcare engagement, exacerbating HIV risks. Muncan et al. (2020) documents perceptions of PWID as 'junkies' in New York City (379 citations). This affects PrEP uptake in criminalized environments.
Cost-Effectiveness Variability
PrEP's value hinges on epidemic context and adherence levels. Gomez et al. (2013) review stresses prioritizing high-incidence PWID groups (245 citations). Scaling requires tailored models beyond general MSM data like Traeger et al. (2018) (433 citations).
Essential Papers
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities
Ayesha B. M. Kharsany, Quarraisha Abdool Karim · 2016 · The Open AIDS Journal · 953 citations
Global trends in HIV infection demonstrate an overall increase in HIV prevalence and substantial declines in AIDS related deaths largely attributable to the survival benefits of antiretroviral trea...
Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa
Monisha Sharma, Roger Ying, Gillian A.M. Tarr et al. · 2015 · Nature · 499 citations
Attitudes and Acceptability on HIV Self-testing Among Key Populations: A Literature Review
Carmen Figueroa, Cheryl Johnson, Annette Verster et al. · 2015 · AIDS and Behavior · 464 citations
HIV self-testing (HIVST) is a potential strategy to overcome disparities in access to and uptake of HIV testing, particularly among key populations (KP). A literature review was conducted on the ac...
Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis
Michael W. Traeger, Sophia Schroeder, Edwina Wright et al. · 2018 · Clinical Infectious Diseases · 433 citations
Findings highlight the importance of efforts to minimize STIs among PrEP users and their sexual partners. Monitoring of risk compensation among MSM in the context of PrEP scale-up is needed to asse...
“They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City
Brandon Muncan, Suzan M. Walters, Jerel M. Ezell et al. · 2020 · Harm Reduction Journal · 379 citations
The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies
Gabriela B. Gomez, Annick Bórquez, Kelsey K. Case et al. · 2013 · PLoS Medicine · 245 citations
Our review identifies the main considerations to address in assessing cost-effectiveness analyses of a PrEP intervention--cost, epidemic context, individual adherence level, PrEP programme coverage...
Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature
Rogério M. Pinto, Kathryn R. Berringer, Rita M. Melendez et al. · 2018 · AIDS and Behavior · 235 citations
Reading Guide
Foundational Papers
Start with Escudero et al. (2014) on PWID acceptability (65 citations) for core evidence, then Gomez et al. (2013) cost models (245 citations) to understand scalability, followed by Escudero et al. (2014) review (34 citations) for trial synthesis.
Recent Advances
Study Muncan et al. (2020) on stigma (379 citations) for implementation barriers, Pinto et al. (2018) multilevel interventions (235 citations), and Tan et al. (2017) guidelines (221 citations) for policy integration.
Core Methods
Core techniques encompass acceptability assessments (Escudero et al. 2014), adherence meta-analyses (Sidebottom et al. 2018), cost-effectiveness modeling (Gomez et al. 2013), and stigma qualitative interviews (Muncan et al. 2020).
How PapersFlow Helps You Research Preexposure Prophylaxis PWID
Discover & Search
Research Agent uses searchPapers and exaSearch to find PWID-specific PrEP studies like Escudero et al. (2014) on acceptability (65 citations), then citationGraph reveals connections to Kerr and Marshall's harm reduction work, while findSimilarPapers uncovers related adherence reviews.
Analyze & Verify
Analysis Agent applies readPaperContent to extract adherence data from Sidebottom et al. (2018), verifies claims with CoVe against Muncan et al. (2020) stigma findings, and runs PythonAnalysis for meta-analysis of efficacy rates using pandas on trial outcomes, with GRADE grading for evidence quality in implementation studies.
Synthesize & Write
Synthesis Agent detects gaps in PWID-specific cost models versus MSM data via gap detection, flags contradictions in adherence reports, and uses exportMermaid for visualizing intervention flows; Writing Agent employs latexEditText, latexSyncCitations for Escudero papers, and latexCompile for grant proposals on PrEP scale-up.
Use Cases
"Meta-analyze PrEP adherence rates in PWID trials from 2013-2020"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of adherence percentages from Escudero et al. 2014 and Sidebottom et al. 2018) → GRADE-graded summary table exported as CSV.
"Draft LaTeX review on PrEP stigma barriers for PWID"
Synthesis Agent → gap detection → Writing Agent → latexEditText (integrate Muncan et al. 2020 quotes) → latexSyncCitations (add Gomez et al. 2013) → latexCompile → PDF with integrated bibliography.
"Find open-source code for PWID PrEP cost-effectiveness models"
Research Agent → paperExtractUrls (Gomez et al. 2013) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis sandbox tests model on sub-Saharan data from Kharsany et al. 2016.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ PWID PrEP papers: searchPapers → citationGraph → DeepScan 7-step analysis with CoVe checkpoints on adherence claims from Pinto et al. (2018). Theorizer generates hypotheses on stigma-PrEP integration by synthesizing Muncan et al. (2020) with Escudero et al. (2014), outputting Mermaid diagrams of causal pathways.
Frequently Asked Questions
What defines PrEP for PWID?
PrEP for PWID uses daily tenofovir to prevent HIV in people who inject drugs, focusing on trials like the Bangkok Tenofovir Study reviewed by Escudero et al. (2014).
What are key methods in PWID PrEP studies?
Methods include acceptability surveys (Escudero et al. 2014, 65 citations), systematic reviews of adherence (Sidebottom et al. 2018, 235 citations), and multilevel interventions (Pinto et al. 2018, 235 citations).
What are seminal papers on PWID PrEP?
Foundational works are Escudero et al. (2014) on acceptability (65 citations) and Gomez et al. (2013) on cost-effectiveness (245 citations); recent include Muncan et al. (2020) on stigma (379 citations).
What open problems exist in PWID PrEP research?
Challenges persist in real-world adherence beyond trials (Sidebottom et al. 2018), overcoming stigma barriers (Muncan et al. 2020), and optimizing costs for criminalized settings (Gomez et al. 2013).
Research HIV, Drug Use, Sexual Risk with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Preexposure Prophylaxis PWID with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the HIV, Drug Use, Sexual Risk Research Guide